4//SEC Filing
Bertolino Arthur Peter 4
Accession 0001123292-17-001401
CIK 0001355250other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 6:26 PM ET
Size
7.2 KB
Accession
0001123292-17-001401
Insider Transaction Report
Form 4
Bertolino Arthur Peter
Pres. & Chief Medical Officer
Transactions
- Award
Class A Common Stock
2017-09-01+1,066,667→ 1,871,254 total - Award
Employee Stock Option (right to buy)
2017-09-01+617,839→ 617,839 totalExercise: $0.71Exp: 2027-09-01→ Class A Common Stock (617,839 underlying)
Footnotes (2)
- [F1]Represents restricted stock which vests in two equal annual installments beginning on September 1, 2018 or upon the occurrence of certain events.
- [F2]The option vests in two equal annual installments on September 1, 2018 and 2019 or upon the occurrence of certain events.
Documents
Issuer
Innovation Pharmaceuticals Inc.
CIK 0001355250
Entity typeother
Related Parties
1- filerCIK 0001426344
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 6:26 PM ET
- Size
- 7.2 KB